Akanda Corp.
$3.42
▼
-0.99%
2026-04-21 05:12:00
www.akandacorp.com
NCM: AKAN
Explore Akanda Corp. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$1.89 M
Current Price
$3.42
52W High / Low
$209.03 / $2.29
Stock P/E
—
Book Value
$22.67
Dividend Yield
—
ROCE
-102.48%
ROE
-60.86%
Face Value
—
EPS
$696.8
Exp Qtr EPS
—
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
—
Beta
1.73
Debt / Equity
11.85
Current Ratio
1.25
Quick Ratio
1.39
Forward P/E
—
Price / Sales
0.4
Enterprise Value
$-2.04 M
EV / EBITDA
0.56
EV / Revenue
-2.44
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Indivior Pharmaceuticals, Inc. | $32.42 | 31.62 | $3.95 B | — | 92.33% | -96.33% | $38 / $8.69 | $-0.78 |
| 2. | Cronos Group Inc. | $2.76 | — | $1.4 B | — | -1.7% | -0.26% | $4.66 / $2.35 | $2.87 |
| 3. | Perrigo Company plc | $12.04 | — | $1.66 B | 9.63% | 4.16% | -38.66% | $28.43 / $9.22 | $21.33 |
| 4. | Phibro Animal Health Corporation | $56.51 | 24.91 | $2.29 B | 0.85% | 10.35% | 31.8% | $60.08 / $16.16 | $8.2 |
| 5. | Caring Brands, Inc. | $1.25 | — | — | — | -157.44% | -2.17% | $6 / $0.06 | $0.14 |
| 6. | China Pharma Holdings, Inc. | $0.67 | — | $26.84 M | — | -46.43% | -20.91% | $2.6 / $0.5 | $1.47 |
| 7. | Assertio Holdings, Inc. | $18.14 | — | $116.08 M | — | -12.35% | -28.25% | $20.45 / $8.55 | $14.63 |
Quarterly Results
Figures shown in M / B
| Sales |
|---|
| Operating Profit |
| Net Profit |
| EPS in Rs |
Profit & Loss
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Sales | 0.84 M | 0.42 M | 2.62 M | 0.04 M |
| Operating Profit | -4.38 M | -3.66 M | -20.18 M | -2.57 M |
| Net Profit | -4.1 M | -32.28 M | -11.66 M | -8.13 M |
| EPS in Rs | -7.66 | -60.39 | -21.81 | -15.22 |
Balance Sheet
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Total Assets | 7.91 M | 8.84 M | 39 M | 8.05 M |
| Total Liabilities | 3.64 M | 12.67 M | 12.1 M | 10.25 M |
| Equity | 4.28 M | -3.83 M | 26.9 M | -2.2 M |
| Current Assets | 5.06 M | 1.81 M | 3.82 M | 3.98 M |
| Current Liabilities | 3.64 M | 10.17 M | 9.35 M | 8.27 M |
Cash Flow
Last available yearly cash flow history
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Operating CF | -3.98 M | -1.5 M | -11.47 M | -6.56 M |
| Investing CF | -1.02 M | 0.02 M | -4.22 M | -0.58 M |
| Financing CF | 8.99 M | 1.49 M | 14.14 M | 11.24 M |
| Free CF | -6.08 M | -1.5 M | -11.78 M | -7.13 M |
| Capex | -2.1 M | -0 M | -0.31 M | -0.58 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 97.47% | -83.83% | 6223% | — |
| Earnings Growth % | 87.31% | -176.86% | -43.37% | — |
| Profit Margin % | -489.57% | -7617.74% | -445% | -19625.88% |
| Operating Margin % | -523.8% | -863.57% | -770.18% | -6203.45% |
| Gross Margin % | 24.91% | 14.01% | 124.81% | -3.84% |
| EBITDA Margin % | -361.82% | -798.19% | -166.31% | -5199.42% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2026-01-12 | 1:0.2 |
| 2025-08-26 | 1:0.32 |
| 2024-11-14 | 1:0.5 |
| 2024-05-23 | 1:0.025 |
| 2023-03-09 | 1:0.1 |